Brief: Abbisko Cayman Says U.S. FDA Clears IND Application For ABSK141
01/12/2025 10:17
Dec 1 (Reuters) - Abbisko Cayman Ltd 2256.HK: U.S. FDA CLEARS IND APPLICATION FOR ABBISKO'S ABSK141 Further company coverage: 2256.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Abbisko Cayman
See all newsHK-listed Abbisko climbs most in 12 weeks on Eli Lilly tie-up
Abbisko Therapeutics enters potential $1.9 billion R&D deal with Eli Lilly (updated)
Brief: Abbisko Therapeutics Deepens R+D- Collaboration With Lilly
Abbisko Therapeutics enters potential $1.9 billion R&D deal with Eli Lilly
Brief: Abbisko Therapeutics Enters Strategic Research Collaboration And License Agreement With Eli Lilly